Objectives: A recent review of ultrasound (US) studies in osteoarthritis (OA) showed very limited data about hand OA. Previous US studies in patients with OA described a degree of overlap between the US appearance of rheumatoid arthritis (RA) and OA joints. The present study aimed to assess the US features of subclinical inflammation in RA and hand OA, using the same US examination protocol.
Rheumatism (EULAR) initiative was designed to help clinicians to diagnose hand OA rather than classifying it by identifying clinical subsets, which help to differentiate OA from other hand joint pathology (Zhang et al., 2009) . A Framingham analysis of the incidence of hand OA showed an age-standardized prevalence of 44.2% in women and 37.7% in men (Haugen et al., 2011) , suggesting a significant possibility of an overlap of OA with other joint pathology.
In terms of imaging hand OA, it is widely accepted that radiography is the gold standard, and that other imaging techniques are rarely indicated for diagnosis (EULAR recommendation 9) (Zhang et al., 2009) . Recent studies evaluated the role of ultrasound (US) examination of hand joints for the diagnosis and prediction of disease progression in hand OA. In a large general population study, hand OA was detected by US in up to 70% of subjects, and was more frequently found at the DIP level (Abraham, Pearce, Mann, Francis, & Birrell, 2014) .
In comparison with OA, the role of US in the early diagnosis and periodic follow-up of patients with rheumatoid arthritis (RA) is well established. It has been shown that US can improve the sensitivity of ACR 2010 classification criteria for RA (Nakagomi et al., 2013), helping clinicians to decide which patients should be started on treatment. US parameters could also help to predict which patients are likely to respond to biologic therapy (Ellegaard et al., 2011) , and were sensitive to change following intra-articular injection with steroids (Terslev, Torp-Pedersen, Qvistgaard, Danneskiold-Samsoe, & Bliddal, 2003) .
In a real-life context, clinicians face the difficulty of differentiating between the most frequent two types of inflammatory arthritis that affect the hands: RA and OA (Haugen et al., 2011 ) -in particular, when the clinical examination is equivocal. Our study aimed to investigate the usefulness of a standardized US examination protocol for hand joints in differentiating subclinical RA from OA, in patients with an equivocal clinical examination. In addition, we explored which simplified hand US scores perform better for each of these diseases separately.
| METHODS

| Patient recruitment
This was a real-life, cross-sectional study, which evaluated patients referred to our US rheumatology outpatient clinics, presenting with inflammatory-sounding hand joint pains between January 2012 and August 2015. The data were collected from the department database, which included all patients referred for a US scan of their joints (to help with their diagnosis of different types of hand arthropathy, to exclude ongoing inflammation in patients already diagnosed with RA, to help with their diagnosis of different types of hand arthropathy or exclude ongoing inflammation in patients already diagnosed with RA, etc.).
For each patient, a set of demographic, clinical and laboratory measurements was recorded at the time of the scan, as well as their provisional diagnosis. In this period, we scanned 73 patients with OA and 224 patients RA. Patients diagnosed with both RA and significant hand OA (as established by US and X-ray), or other type of associated joint pathology (such as crystal-related arthropathy or psoriatic arthritis), were excluded from the study. In the event of any missing information in the outpatient clinic proforma generated in the US clinic at the time of clinical and US examination, the records were completed by consulting the patient electronic hospital records. No inclusion or exclusion criteria were applied for the selection of patients, as all the patients with RA or OA referred by their consultant to have a US scan of their hand joints were included in our study analysis.
As we captured data collected during the US clinics, we are fully aware that we would not have captured data from patients with a definitive diagnosis of OA of the DIP joints or with obvious synovitis in the context of RA whose clinicians did not consider the need for an additional US examination. We used the ACR hand OA and 2010 ACR/EULAR RA classification criteria for diagnosing OA and RA, respectively.
| Disease assessment
We used the same set of reported outcomes and clinical and laboratory parameters for all the patients, to ensure homogeneity of the collected data. We collected information about disease duration (in months); clinical joint examination findings, including tender joint count (TJC) and swollen joint count (SJC); as well as a patient-reported global assessment score (GVAS).
Additional data about the serum levels of high-sensitivity Creactive protein, erythrocyte sedimentation rate (ESR), and the presence of rheumatoid factor (RF), anticitrullinated cyclic peptide antibodies (ACPAs) and antinuclear antibodies (ANAs) were also collected at the time of the scan.
| Treatment details
For each patient, a detailed record was compiled of their medication at the time of the US scan, including paracetamol, nonsteroidal antiinflammatory drugs, disease-modifying drugs (DMARDs), biologic therapies and steroids, given either orally or by intramuscular depot injection.
| US examination
We used an established protocol of US examination of the hands, comprising flexor tendons and 22 joint assessments (dorsal longitudinal and transverse views of the wrist, and MCP and PIP joints), which is standard of practice for our US clinics. We assessed 22 hand joints in every patient, irrespective of their hand symptoms, using the OMERACT scoring system for US examination.
US examination was performed using an Logiq S8 US machine (GE Medical Systems Ultrasound and Primary Care Diagnostics, Wauwatosa, WI, USA), equipped with a multifrequency linear matrix array transducer (6-15 MHz). B-mode and power Doppler (PD) machine settings were optimized and standardized for all US examinations. The settings used were: B-mode frequency 11-15 MHz, depending on the depth of the anatomical area; Doppler frequency 7.5-15, depending on the depth of the anatomical area; and low-wall filters and pulse repetition frequency around 800 Hz. As only a small number of joints had a PD signal (only patients with an equivocal clinical examination were referred for a US examination of their hands for suspicion of subclinical inflammation), we did not report the grades of the PD signal separately, although they were used to generate the total PD score for every patient.
We recorded information about synovial hypertrophy (SH) grade, presence of erosions, PD signal, joint effusion, osteophytes (OP) and tendon abnormalities. We calculated the total PD score per patient as a sum of the different PD grades found at the 22-joint examination;
we calculated the SH scores in a similar fashion.
| Statistical analysis
All data were transferred and collated from paper questionnaires to a Microsoft Excel spreadsheet (Microsoft Excel 2013, Microsoft Office USA). Using IBM SPSS Statistics 22 for further analysis and statistical tests, descriptive statistics were used to explore the patients with seropositive RA and OA further, using mean and standard deviation (SD), and median with interquartile range (IQR), depending on the data distribution. The Mann-Whitney U test was implemented to compare different joint scoring systems for both OA and RA. A p-value of <0.05 was considered statistically significant.
| Ethical issues
The data were collected according to the standard of practice in our department. The study analysed retrospectively the results of the US examinations of patients seen in our US clinics over a defined period of time. The local ethics committee was aware that the data were collected according to the standard of practice in our department and no ethical approval or patient consent was required as no patient information was used for teaching or new intervention research. The results of our analysis had no impact on the clinical management of patients, and their confidentiality was maintained. Our US clinic database, which generated the results reported in this article supported our department periodic service evaluation activities.
3 | RESULTS
| Patient demographics
We compared the two groups of interest, comprising 73 patients with OA and 224 patients with RA. The mean age of patients was greater in the OA group (60.6 AE 9.9 years) than the RA group (53.8 AE 15.3 years) (p < 0.05). We found a similar proportion of female patients (80.8%) in the OA group and the RA group (81.3%). Of the RA patients, 165 (73.6%) were being treated with DMARDs and 65 (29%) with biologics at the time of the US scan. None of the hand OA patients included in our study were being treated with DMARDs (Table 1) .
To assess the level of consistency between the SJC, GVAS and TJC scores for both groups of patients, the Cronbach's alpha statistical test was applied. There was a low consistency between these three assessments for the RA group (α = 0.308), and a very poor correlation between clinical examination and patients' reported outcomes for the OA group (α = −0.022).
We investigated the differences between the US assessments in patients with RA versus OA, and, as expected, chronic inflammatory features and the PD signal were more frequently recorded in patients with RA. As all the patients referred for a US scan had an equivocal clinical examination and required this scan to help with their disease activity assessment or diagnosis, the number of joints with inflammatory changes or OP was rather small; therefore, we reported the median values of the numbers of joints with a particular US finding (Table 2) . As the patients included in our study had rather subclinical inflammation in the context of both RA and OA, we also reported the percentage of patients with no evidence of the various US abnormalities as this was a frequent encounter (zero values).
As the patients included in our study did not have a definitive clinical picture of hand OA or active synovitis associated with RA, we have also reported the differences in the number of patients with present (nonzero values) and absent (zero values) US features between the two patient groups.
There was no statistically significant difference between the RA and OA groups when we compared the number of patients with zero values for certain US parameters (osteophytes, PD signal or erosions), as expected, as the majority of patients did not have obvious clinical features of OA or clinical synovitis (Table 3) . However, Mann-Whitney test comparisons between the numbers of patients with at least one joint with SH grade 3 showed a significant difference between RA and OA groups when we excluded the patients with no SH grade 3 in any of their joints, suggesting that if significant SH is present, the patients are more likely to have RA than OA. As expected, the numbers of OP in the wrists MCP and PIP joints were significantly higher in patients with OA.
| DISCUSSION
The present study compared the ability of a comprehensive 22-joint US examination protocol to detect subclinical inflammation in two Hand US examination facilitated the diagnosis of hand OA (by excluding mimicking pathology) and assessed for the presence of subclinical inflammation in both disease groups. The patients included in the study were referred by their clinicians to have a US scan of their hands for a clinical reason (e.g. disparity between RA-associated symptoms and clinical evidence of synovitis; a lack of correlation between inflammatory markers, patient-reported outcomes and physician assessment of disease activity; to confirm active inflammation in certain joints that can be amenable to intra-articular injections in hand OA; or to provide reassurance that there was no superimposed inflammatory pathology in patient with hand OA, etc.).
Our study results showed that inflammatory markers were not useful in differentiating between the group of patients with subclinical RA and those with hand OA on the whole; however, the patients with RA had more swollen and tender joints and higher pain scores than those with OA (as expected in the context of a longstanding inflammatory disease).
The US parameters that helped to differentiate between RA and hand OA were: the presence of a PD signal and erosions (more frequently found in patients with RA) and OP (more frequently found in patients with OA). Interestingly, US-detected SH was not different in terms of the frequency of joints affected and grading between the two groups; however, SH grade 3 was more frequent in patients with RA versus OA, but only when patients with some degree of chronic swelling were compared.
Previous studies showed that erosive hand OA was associated with US-detectable inflammatory changes in the affected joints (Mancarella et al., 2010) . We found only one previous study assessing comparatively patients with either hand OA or RA; this study compared the ability of US and photo-optical imaging to detect inflammatory changes in patients with PIP joint OA, and patients with RA, when compared with healthy volunteers (Amitai et al., 2015) .
No clear cut-off between the types of US-detected inflammatory changes that can differentiate subclinical RA from hand OA was ever established. Our study found that the median number of joints with moderate degrees of SH was similar between both diseases, and only the severe SH was more frequently encountered in patients with RA, suggesting that establishing a cut-off value based on the number of joints with SH alone to enable a differential diagnosis between the two diseases is not feasible. However, the proportion of patients with a PD signal was significantly different between the two diseases (8.2%
of patients with hand OA and 46.4% of RA patients had active inflammation in their joints), as was the proportion of erosions (42.5% in the OA group versus 70.1% in the RA group) and of OP (84.9% in the OA group versus 55.4 in the RA group). The present study has raised awareness that chronic and active inflammatory changes are encountered in both RA and OA, although the proportion of patients with active inflammation was significantly higher in patients with RA, whereas the proportion of patients with chronic inflammatory changes in their joints was similar. When we compared only the RA and OA patients with SH detected by US, a higher proportion of RA patients had severe SH, which suggested that if there is evidence of chronic inflammation, this is likely to be more severe in RA when compared with hand OA.
US-detected joint inflammation was effective in predicting the development of OP in patients with hand OA in several longitudinal studies (Kortekaas, Kwok, Reijnierse, & Kloppenburg, 2015) . There is controversy regarding the correlation between hand pain in OA and the level of inflammation detected by US examination. Although one study found no correlation between hand pain and US-detected inflammatory features in OA (Kortekaas, Kwok, Reijnierse, Huizinga, & Kloppenburg, 2014) , another concluded that pain in OA is associated with inflammation, which can be detected by US (Kortekaas et al., 2010) . Erosive OA was associated with more frequent US inflammatory features when compared with patients with non-erosive OA, and was also found to affect a large proportion of patients with hand OA (51% of patients with hand OA were found to have erosions in another study) (Kortekaas, Kwok, Reijnierse, Huizinga, & Kloppenburg, 2013 ). In addition, US detected joint inflammation was associated with the development of new erosions in a longitudinal study of patients with hand OA (Mancarella et al., 2015) . In our study, 42.5% of OA patients had erosions in at least one joint; this can be considered comparable with the previously reported data, especially when considering that patients with obvious OP and joint deformities were excluded from our cohort.
The presence of chronic inflammatory changes which lead to erosions is very well documented in subclinical RA (Nguyen et al., 2014) , and previous efforts have attempted to establish the best US scoring systems (Naredo, et al. 2013) ; however, fewer data are available for patients with hand OA. Inflammatory changes were found in joints unaffected by erosions in patients with erosive hand OA, suggesting an initial inflammatory process, or a possible systemic cause for erosive joint disease in this category of patients (Kortekaas et al., 2013) . It was found that the US evaluation of hand joints correlated with clinical symptoms in patients with hand OA, and showed an improvement following US-guided injections with hyaluronic acid (Klauser et al., 2012) .
It was proposed that the PD signal and cartilage thickness (mm) measurements may represent two useful information tools for hand OA evaluation, which both correlated with radiographic progression (Mancarella et al., 2010) . In our study, 9.2% of OA patients with inflammatory hand pain had a PD signal in their joints, and 42.5% had at least one joint with erosions, both in the context of having longstanding symptoms (IQR = 60 months).
Our cohort study could not provide any suitable information regarding the temporal relationship between the presence of PD, erosions and OP in hand OA. Even if the inflammatory features are present in OA, they are seen in a smaller proportion of patients and affect a smaller number of joints than in patients with RA. In our study, in contrast with OA patients, almost one in two RA patients (46.4%)
had active inflammation in their joints.
| Limitations
Our study did not have strict inclusion criteria to ensure the homogeneity of the OA and RA cohorts analysed; the patients were included based on their clinician's decision to send them for a US scan of their hands, to help with their diagnosis (in the case of OA patients) or to optimize their disease activity assessment (in the case of RA patients).
We did not explore correlations between clinical examination, Disease Activity Score in 28 joints, disease duration or medication, and different US scores, as this was beyond the scope of the study. We did not include US scores assessing DIP or carpometacarpal-1 joints, as the purpose of the study was to use the same US examination protocol for all our patients.
| CONCLUSION
The present real-life cohort study provided evidence that joint inflammatory changes detectable by US characterize both RA and hand OA. Although the proportions of our patients with and without SH were similar within these subgroups, the SH was likely to be more severe in RA when compared with OA. The proportion of patients with a PD signal, erosions and OP differed significantly between the two disease groups, and helped with the patient diagnosis and disease activity assessment, along with clinical, laboratory and other imaging parameters. Our study also showed that almost one in 10 patients with hand OA can have a PD signal compared with one in two in the RA group, and that the inflammatory markers were not particularly useful in differentiating clinically equivocal RA from hand OA.
